DEA "THE EPITOME of INEPTITUDE": MMJ vs DEA Caught in Marijuana Lawsuit as Marijuana Policy Implodes

May 15, 2025 5:00 AM

In the annals of American regulatory dysfunction, few agencies have earned the national embarrassment badge as thoroughly as the Drug Enforcement Administration (DEA). And now, the agency faces yet another federal lawsuit from MMJ International Holdings, MMJ BioPharma Cultivation, and MMJ BioPharma Labs-a pharmaceutical company with two FDA-approved INDs-for doing exactly what it's become notorious for: nothing. Congressman Buddy Carter...

Read more

Genflow Biosciences PLC Announces Key SIRT6 Patent Application

May 15, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, announces that the Japanese Patent Office has advanced its SIRT6-related patent application (Application No. JP 2024515284) to the national examination phase.The application, titled "Variants of SIRT6 for Use in Preventing and/or Treating Age-Related Diseases," was originally filed on 13 May 2022 and is jointly...

Read more

IRLAB to Present at BioStock Global Forum 2025

May 15, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 15, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, today announces that CEO Kristina Torfgård will present IRLAB to potential partners and specialist investors at BioStock Global Forum 2025. The event will take place on May 20-21 in Lund, Sweden.Both Swedish and international investors, as...

Read more

Relief Therapeutics Publishes 2025 Annual General Meeting Agenda

May 15, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published the agenda for its 2025 Annual General Meeting (AGM) of shareholders, to be held on June 12, 2025, at 10:00 a.m. CEST in Geneva, Switzerland. The agenda includes approval of the 2024 annual report and financial statements,...

Read more

Leafbuyer Technologies, Inc. Announces Quarterly Results

May 14, 2025 4:30 PM

Leafbuyer Technologies Inc. ("Leafbuyer" or "the Company") (OTCQB:LBUY), a leading cannabis technology company, announced today that revenue grew 16% and gross profit increased by 44% in the quarter ending March 31, 2025.Leafbuyer's 16% year-over-year revenue growth rate is more than double the industry's projected compound annual growth rate of 7.5%, according to New Frontier Data. Increased sales of the Company's loyalty, texting, online...

Read more

Bausch Health Announces 2025 Annual Meeting of Shareholder Results

May 14, 2025 4:15 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual Meeting") held on May 13, 2025. The detailed results of the vote for the election of directors are set out below:Name For Withheld Broker Non-VotesThomas J. Appio 208,400,572 5,943,436 56,339,806Christian A. Garcia 207,181,762 7,162,246 56,339,806Brett M. Icahn 199,179,508 15,164,500...

Read more

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 14, 2025 4:05 PM

Net income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectivelyAdjusted EBITDA1 of $3.9 millionTotal net revenue of $18.5 million up 32% year-over-yearCompany to host conference call and webcast today, May 14, 2025, at 4:30 p.m. Eastern timeDENVER, CO / ACCESS Newswire / May 14, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel...

Read more

CV Sciences, Inc. Reports First Quarter 2025 Financial Results

May 14, 2025 4:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2025.First Quarter 2025 and Recent Financial and Operating HighlightsGenerated revenue of $3.6 million for the first quarter 2025 compared to $4.0 million for...

Read more

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025

May 14, 2025 3:30 PM

Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2025.Revenue for the quarter ended March 31, 2025 was $13.9 million compared to $13.1 million for the quarter ended March 31, 2024, an increase of $0.8 million or 6.1%. The Company had operating income in the quarter ended March 31, 2025 of approximately $0.7 million compared to $0.4 million in the quarter ended March...

Read more

Emergency Care Partners Recognized as One of the Best Places to Work in Healthcare in 2025

May 14, 2025 1:45 PM

Emergency Care Partners (ECP) has been selected by Modern Healthcare as one of the 2025 Best Places to Work in Healthcare. The complete list of this year's winners, in alphabetical order, is available at ModernHealthcare.com/bestplaceslist. Modern Healthcare will publish a special supplement featuring a ranked list of all the winners along with the October 13, 2025, issue of MH magazine."Being recognized as a 2025 Best Place to Work in...

Read more

Communiqué from the Annual General Meeting of AlzeCure Pharma on 14 May 2025

May 14, 2025 11:45 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - Today, 14 May 2025, the annual general meeting was held in AlzeCure Pharma AB (publ) (the "Company"). Below is a summary of the resolutions made. All resolutions were passed with the required majority.Resolution regarding the adoption of the accounts and allocation of the Company's resultThe annual general meeting resolved to adopt the profit and loss statement and the balance sheet. The annual general...

Read more

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

May 14, 2025 11:30 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, will release its financial results for the second quarter of fiscal year 2025 (ended on March 31, 2025) after the close of the U.S. equity markets on Thursday, May 15, 2025. The Company's Form 10-Q for the period will be filed concurrently and available on the SEC Filings page of its Investor Relations...

Read more

IntusCare Announces PACE Organization of Rhode Island is First to Deploy Innovative EMR and Practice Management System Platform

May 14, 2025 11:00 AM

IntusCare, a technology leader in the PACE market, today announced that PACE Organization of Rhode Island (PACE-RI) has officially gone live with IntusCare CareHub, an EMR and practice management system built for PACE's value-based care model. PACE-RI is one of the nation's most innovative Programs of All-Inclusive Care for the Elderly (PACE). The successful launch marks a major milestone in a years-long partnership between the two organizations...

Read more

Nurses Continue to Name EHRs a Top Driver of Burnout and Resignation in 2025, Black Book Nurses' Week Survey

May 14, 2025 10:00 AM

A national 8-month survey conducted by Black Book Research of over 9,000 U.S. nurses - including those working in hospitals, surgery centers, physician practices, and outpatient facilities - reveals a growing disconnect between frontline nursing staff and the electronic health records (EHRs) they are expected to rely on every shift. The findings expose how poor EHR usability is not only contributing to nurse burnout but also actively driving...

Read more

Desert Oasis Healthcare Leads the Way in Dementia Detection with Cutting-Edge Digital Screening Tool

May 14, 2025 10:00 AM

In a bold move to improve early detection and care for seniors at risk of dementia and Alzheimer's disease, Desert Oasis Healthcare (DOHC) has partnered with Neurotrack, a digital health company that is transforming cognitive screening across the nation. Through this collaboration, DOHC is now using Neurotrack's FDA-registered, clinically trusted cognitive assessment tool during routine wellness visits to better identify and support patients...

Read more

Cognixion and Blackrock Neurotech Expand Access to Non-Invasive, Multi-Modal BCI Research with Axon-R

May 14, 2025 9:00 AM

Cognixion, a leading developer of non-invasive brain-computer interface (BCI), artificial intelligence (AI) and augmented reality (AR) technology, today announced that Blackrock Neurotech, a leading developer of implantable BCIs, will offer Cognixion's Axon-R wearable neural interface platform to research institutions through its distribution network.Cognixion and Blackrock Neurotech maintain independent development activities but share a common...

Read more

Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates

May 14, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast tomorrow, Thursday, May 15, 2025, at 4:15 p.m. Eastern to review first-quarter 2025 financials and provide corporate updates.Participation Instructions for Investor WebcastWhen: Thursday, May 15, 2025 at 4:15 PM Eastern Standard TimeParticipant Registration & Access Link: Click HereAbout the Jaguar Health Family of CompaniesJaguar Health, Inc....

Read more

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 14, 2025 9:00 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical skin diseases and aesthetic applications, today highlighted recent corporate progress and reported financial results for the first quarter ended March 31, 2025."It was an exciting quarter for our team to announce positive topline results of the XYNGARI™ Phase 3 STAR-1 trial for the treatment...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) To Release First Quarter 2025 Results on Monday, May 19th

May 14, 2025 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced it will release first quarter 2025 results on Monday, May 19, 2025. After filing its Form 10-Q, the Company will also publish a shareholder letter providing a broader update on the Company's business. TRNR expects to file the required...

Read more

Bulletin from the 2025 Annual General Meeting of Spago Nanomedical AB

May 14, 2025 8:30 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The Annual General Meeting (AGM) of Spago Nanomedical AB (publ) was held today, May 14, 2025, at which the AGM resolved to approve the income statement and balance sheet for 2024 and discharge the Board members and the CEO from liability for the financial year 2024.The following resolutions were also passed at the AGM:Disposition of results and discharge from liabilityIn accordance with the board's...

Read more